Coriolis Pharma and U-Medico Announce a Strategic Alliance
MARTINSRIED, Germany and OSAKA, Japan, March 17, 2022 / B3C newswire /
-- Coriolis Pharma, a globally operating service provider and one of
the world leaders in formulation research and development of
(bio)pharmaceutical drugs located in Germany, and U-Medico, an
innovative formulation development and biophysical characterisations
service provider located in Japan, today announce a strategic alliance
that includes an equity investment by Coriolis Pharma into U-Medico.
More info >> |